Cadonilimab plus chemotherapy versus PD-1 inhibitor plus chemotherapy as first-line (1L) treatment for advanced gastric (G) or gastroesophageal junction (GEJ) cancer with PD-L1 CPS 5: A ...
Recurrence-free survival as a surrogate for overall survival in esophageal squamous cell carcinoma: Nationwide real-world data from Japan. Safety and short-term efficacy of adjuvant nivolumab after ...
MedPage Today on MSN
For Your Patients: Next Steps After Treatment of Gastric Cancer
Physical and psychological recovery and beyond ...
Globally, gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer-related death, with China bearing nearly half of these cases. These figures underscore an urgent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results